Video

VIDEO: A fib screening finds 5% of elderly undiagnosed


 

AT THE ESC CONGRESS 2014

References

BARCELONA – Roughly 5% of people aged 75 years or older have undiagnosed atrial fibrillation, based on a population-based screening study in Sweden that has assessed nearly 7,000 people, Dr. Mårten Rosenqvist said during an interview at the annual congress of the European Society of Cardiology.

Once diagnosed with atrial fibrillation, all these people immediately qualified for anticoagulant treatment because of their age-related stroke risk. The StrokeStop study will follow all the screened people for 5 years, as well as a concurrently assembled cohort of unscreened controls, to determine the benefit from screening for preventing strokes. “If we can reduce the rate of stroke, it would be a reason to implement a national atrial fibrillation screening program” for all people aged 75 years and older, said Dr. Rosenqvist, professor of cardiology at the Karolinska Institute in Stockholm.

Dr. Rosenqvist said that he is a consultant to Zenicor, a company that markets an ECG-based device for diagnosing atrial fibrillation being used in the StrokeStop study. He also is a consultant to several drug companies.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

mzoler@frontlinemedcom.com

On Twitter@mitchelzoler

Recommended Reading

Resuming aspirin for cardioprotection after GI bleed tied to 38% cut in CV risk
MDedge Internal Medicine
Prolonged monitoring found best for detecting AF after cryptogenic stroke
MDedge Internal Medicine
Increased risk of heart attack confirmed in Sjögren’s syndrome patients
MDedge Internal Medicine
USPSTF: Don’t screen general population for carotid stenosis
MDedge Internal Medicine
Stress, negative emotions may up stroke and TIA risk
MDedge Internal Medicine
Stroke incidence down in whites and blacks across the U.S.
MDedge Internal Medicine
Plan helped atrial fibrillation patients safely switch oral anticoagulants
MDedge Internal Medicine
VIDEO: Rivaroxaban provides advantages for cardioversion in AF
MDedge Internal Medicine
Rivaroxaban shows advantages in AF cardioversion
MDedge Internal Medicine
Stroke risk skyrocketed after intracranial hemorrhage in warfarin users
MDedge Internal Medicine